sur CureVac (NASDAQ:CVAC)
CureVac Announces Financial Results and Business Update for 2024
CureVac N.V., a global biotech company based in Germany and the US, plans to release its financial results for the fourth quarter and full-year 2024 on April 10, 2025. The company, renowned for its mRNA-based technologies, will also provide a business update on this date. A conference call and webcast will occur at 3 p.m. CET/9 a.m. EST to discuss these results. Interested parties can access the webcast via CureVac's website.
CureVac's advances in mRNA technology have positioned it as a pioneer in the field, contributing significantly to COVID-19 vaccine development. The company is now expanding the use of mRNA into new therapeutic areas, including personalized cancer vaccines and prophylactic treatments.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de CureVac